Distinct trajectories of long‐term symptom severity in pediatric obsessive–compulsive disorder during and after stepped‐care treatment

2019 ◽  
Vol 61 (9) ◽  
pp. 969-978
Author(s):  
Sanne Jensen ◽  
Davíð R.M.A. Højgaard ◽  
Katja A. Hybel ◽  
Erik Lykke Mortensen ◽  
Gudmundur Skarphedinsson ◽  
...  
Keyword(s):  
Obsessive Compulsive Disorder ◽  
Symptom Severity ◽  
Stepped Care ◽  
Obsessive Compulsive ◽  
Compulsive Disorder ◽  
Care Treatment

51.3 THE NORDIC LONG-TERM OBSESSIVE-COMPULSIVE DISORDER TREATMENT STUDY: EFFECTIVENESS OF A STEPPED-CARE TREATMENT

2016 ◽  
Vol 55 (10) ◽  
pp. S340-S341
Author(s):  
Tord Ivarsson ◽  
Gudmundur A. Skarphedinsson ◽  
Nor Christian Torp ◽  
Kitty Dahl ◽  
Per Hove Thomsen ◽  
...  
Keyword(s):  
Obsessive Compulsive Disorder ◽  
Stepped Care ◽  
Obsessive Compulsive ◽  
Compulsive Disorder ◽  
Care Treatment ◽  
Disorder Treatment

Couple-Based Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder

2021 ◽  
pp. 370-383
Author(s):  
Jennifer L. Buchholz ◽  
Jonathan S. Abramowitz ◽  
Samantha N. Hellberg ◽  
Heidi J. Ojalehto
Keyword(s):  
Obsessive Compulsive Disorder ◽  
Symptom Severity ◽  
Behavioral Therapy ◽  
Response Prevention ◽  
Obsessive Compulsive ◽  
Global Functioning ◽  
Interpersonal Dynamics ◽  
Case Examples ◽  
Compulsive Disorder

For a number of reasons, it may be critical to involve a romantic partner or spouse in exposure and response prevention (ERP) for obsessive-compulsive disorder (OCD). Indeed, relationship stress focal to OCD is associated with greater symptom severity, a more severe course, and poor global functioning. Research also indicates that involving partners or spouses to serve as coaches for their OCD-affected partners during ERP improves the efficacy of this treatment. This chapter describes the nature and treatment of OCD, focusing on interpersonal dynamics, and outlines a couple-based ERP program for individuals with OCD who are in long-term relationships. Case examples are included to illustrate the techniques used in this program.

scholarly journals Parental Accommodation Predicts Symptom Severity at Long-Term Follow-Up in Children with Obsessive–Compulsive Disorder: A Preliminary Investigation

2016 ◽  
Vol 25 (8) ◽  
pp. 2562-2570 ◽  
Author(s):  
Sarah K. Francazio ◽  
Christopher A. Flessner ◽  
Christina L. Boisseau ◽  
Nicholas J. Sibrava ◽  
Maria C. Mancebo ◽  
...  
Keyword(s):  
Obsessive Compulsive Disorder ◽  
Symptom Severity ◽  
Preliminary Investigation ◽  
Obsessive Compulsive ◽  
Compulsive Disorder ◽  
Long Term Follow Up

Long-Term Efficacy of Exposure and Ritual Prevention Therapy and Serotonergic Medications for Obsessive-Compulsive Disorder

CNS Spectrums ◽  
2003 ◽  
Vol 8 (5) ◽  
pp. 363-371 ◽  
Author(s):  
Elizabeth A. Hembree ◽  
David S. Riggs ◽  
Michael J. Kozak ◽  
Martin E. Franklin ◽  
Edna B. Foa
Keyword(s):  
Obsessive Compulsive Disorder ◽  
Symptom Severity ◽  
Obsessive Compulsive ◽  
Term Outcome ◽  
Long Term Outcome ◽  
Treatment Groups ◽  
Compulsive Disorder ◽  
Study Results

ABSTRACTWhat is the long-term outcome of patients with obsessive-compulsive disorder (OCD) who are treatred with exposure and response (ritual) prevention (EX/RP) alone, serotonergic medications alone, or their combination? How is the long-term outcome of these patients affected by the discontinuation? Follow-up assessments were conducted with 62 patients treated for OCD an average of 17 months posttreatment (range: 6–43 months). Patients received one of three treatments: serotonergic medications (fluvoxamine or clomipramine), intensive behavior therapy involving EX/RP, or intensive EX/RP with concurrent antidepressant medication. At follow-up, no differences in OCD symptom severity were found among the three treatment groups. However, when current medication use was taken into consideration, differences among the three treatment groups emerged. Among patients who were medication-free at the time of follow-up assessment (n=37), those in the EX/RP-alone and EX/RP-with-medication groups had lower symptom severity ratings than those in the medication-only group on 4 out of 6 measures. There were no differences in OCD severity ratings among patients taking medications at follow-up (n=25). Although these findings are interpreted with caution due to the uncontrolled nature of the study, results suggested that long-term outcome may be superior following EX/RP than following serotonergic medications, after discontinuation. For patients who remain on medications, the treatment produced benefits equivalent to EX/RP.

Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study

2005 ◽  
Vol 19 (4) ◽  
pp. 392-394 ◽  
Author(s):  
Donatella Marazziti ◽  
Chiara Pfanner ◽  
Bernardo Dell’osso ◽  
Antonio Ciapparelli ◽  
Silvio Presta ◽  
...  
Keyword(s):  
Obsessive Compulsive Disorder ◽  
Obsessive Compulsive ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Compulsive Disorder ◽  
Augmentation Strategy

scholarly journals Demography and symptom severity of obsessive compulsive disorder in Bangladesh: a cross-sectional observation

2020 ◽  
Vol 30 (2) ◽  
pp. 23-26
Author(s):  
Sultana Algin ◽  
Mohammad Waliul Hasnat Sajib ◽  
SM Yasir Arafat
Keyword(s):  
Obsessive Compulsive Disorder ◽  
Symptom Severity ◽  
Large Scale ◽  
Depressive Disorders ◽  
Obsessive Compulsive ◽  
Cross Sectional ◽  
Compulsive Disorder ◽  
Co Morbidity ◽  
Study Results ◽  
Axis I

Obsessive Compulsive Disorder (OCD) is a common disorder and usually runs a chronic course with waxing and waning course. It leads to pervasive impairments in multiple domains of life. The aim of the study was to assess the demographic characteristics of the OCD patients and symptom severity of this disorder. This was a cross-sectional study done in OCD clinic of outpatient department (OPD) of BSMMU, during the period from May, 2015 to April, 2017. Four hundred patients fulfilling the inclusion and exclusion criteria were selected consecutively. After taking written consent a predetermined questionnaire was filled for each patient through face-to-face interview. Then patients were evaluated covering the following areas: Axis I diagnoses (DSM-IV) and Y-BOCS severity scale. The results showed that, the mean age of the respondents was 26.6 (SD±9.9) years, ranging from 8 to 63 years. According to Y-BOCS symptoms severity used for adult patients found that majority (70%) of the patients had moderate to severe sufferings. Male had co-morbid anxiety disorders (panic disorder, agoraphobia, social phobia) more but female patients were found more depressive disorders. Female had more hypothyroidism, diabetes, skin disorders and hypertension than male. These demographic status, co-morbidity profile and symptoms severity can serve as the baseline data for a country like Bangladesh and further large scale, multi-centered study would better generalize the study results. Bang J Psychiatry December 2016; 30(2): 23-26

scholarly journals Executive functioning in Body Dysmorphic Disorder and Obsessive-Compulsive Disorder

2021 ◽  
Author(s):  
Long Long Chen ◽  
Oskar Flygare ◽  
John Wallert ◽  
Jesper Enander ◽  
Volen Ivanov ◽  
...  
Keyword(s):  
Obsessive Compulsive Disorder ◽  
Test Performance ◽  
Symptom Severity ◽  
Body Dysmorphic Disorder ◽  
Spatial Working Memory ◽  
Clinical Severity ◽  
Stop Signal Task ◽  
Healthy Controls ◽  
Obsessive Compulsive ◽  
Compulsive Disorder

Objective: To assess executive functions in patients with Body Dysmorphic Disorder (BDD) and Obsessive-Compulsive Disorder (OCD) compared with healthy controls. Methods: Adults diagnosed with BDD (n=26) or OCD (n=29) according to DSM-5, and healthy controls (n=28) underwent validated and computerized neuropsychological tests; spatial working memory (SWM), Intra- extra dimensional set shifting (IED) and Stop signal task (SST), from the Cambridge Neuropsychological Test Automated Battery (CANTAB). Test performance was compared between groups, and correlated to standardized symptom severity of BDD and OCD. Significance level was set to p<0.05. Results: There were no statistically significant between-group differences on key outcome measures in SWM, IED, or SST. There was a weak positive correlation between symptom severity and test errors on SWM and IED in both OCD and BDD groups; increased clinical severity were associated with more errors in these tests. Further, there was a negative correlation between symptom severity and SST in the BDD group. Conclusions: Patients with BDD or OCD did not differ from healthy control subjects in terms of test performance, however there were several statistically significant correlations between symptom severity and performance in those with BDD or OCD. More studies on EF in BDD and OCD are required to elucidate if there are differences in EF between these two disorders.

Sign in / Sign up

Export Citation Format

Share Document